Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics
Christoph B. Messner, Vadim Demichev, Daniel Wendisch, Laura Michalick, Matthew White, Anja Freiwald, Kathrin Textoris-Taube, Spyros I. Vernardis, Anna-Sophia Egger, Marco Kreidl, Daniela Ludwig, Christiane Kilian, Federica Agostini, Aleksej Zelezniak, Charlotte Thibeault, Moritz Pfeiffer, Stefan Hippenstiel, Andreas Hocke, Christof von Kalle, Archie Campbell, Caroline Hayward, David J. Porteous, Riccardo E. Marioni, Claudia Langenberg, Kathryn S. Lilley, Wolfgang M. Kuebler, Michael Mülleder, Christian Drosten, Martin Witzenrath, Florian Kurth, Leif Erik Sander, View ORCID ProfileMarkus Ralser
doi: https://doi.org/10.1101/2020.04.27.20081810
Christoph B. Messner
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
Vadim Demichev
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
2Department of Biochemistry, The University of Cambridge, Cambridge, CB21GA, United Kingdom
Daniel Wendisch
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Laura Michalick
4Charité Universitätsmedizin Berlin, Institute of Physiology, 10117 Berlin, Germany
Matthew White
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
Anja Freiwald
5Charité Universitätsmedizin Berlin, Core Facility - High Throughput Mass Spectrometry, 10117 Berlin, Germany
Kathrin Textoris-Taube
5Charité Universitätsmedizin Berlin, Core Facility - High Throughput Mass Spectrometry, 10117 Berlin, Germany
Spyros I. Vernardis
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
Anna-Sophia Egger
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
Marco Kreidl
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
Daniela Ludwig
6Charité Universitätsmedizin Berlin, Department of Biochemistry, 10117 Berlin, Germany
Christiane Kilian
6Charité Universitätsmedizin Berlin, Department of Biochemistry, 10117 Berlin, Germany
Federica Agostini
6Charité Universitätsmedizin Berlin, Department of Biochemistry, 10117 Berlin, Germany
Aleksej Zelezniak
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
7Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg SE-412 96, Sweden
Charlotte Thibeault
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Moritz Pfeiffer
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Stefan Hippenstiel
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Andreas Hocke
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Christof von Kalle
8Berlin Institute of Health (BIH), and Charité Universitätsmedizin, Clinical Study Center (CSC), 10117 Berlin, Germany
Archie Campbell
9Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh EH4 2XU, United Kingdom
10Usher Institute, University of Edinburgh, Nine, Edinburgh Bioquarter, 9 Little France Road, Edinburgh, EH16 4UX, United Kingdom
Caroline Hayward
11MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, United Kingdom
David J. Porteous
9Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh EH4 2XU, United Kingdom
Riccardo E. Marioni
9Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh EH4 2XU, United Kingdom
Claudia Langenberg
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
12MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, United Kingdom
Kathryn S. Lilley
2Department of Biochemistry, The University of Cambridge, Cambridge, CB21GA, United Kingdom
Wolfgang M. Kuebler
4Charité Universitätsmedizin Berlin, Institute of Physiology, 10117 Berlin, Germany
Michael Mülleder
5Charité Universitätsmedizin Berlin, Core Facility - High Throughput Mass Spectrometry, 10117 Berlin, Germany
Christian Drosten
13Charité Universitätsmedizin Berlin, Department of Virology, 10117 Berlin, Germany
Martin Witzenrath
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Florian Kurth
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
14Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
Leif Erik Sander
3Charité Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine, 10117 Berlin, Germany
Markus Ralser
1The Francis Crick Institute, Molecular Biology of Metabolism Laboratory, London NW11AT, United Kingdom
6Charité Universitätsmedizin Berlin, Department of Biochemistry, 10117 Berlin, Germany
Article usage
Posted May 03, 2020.
Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics
Christoph B. Messner, Vadim Demichev, Daniel Wendisch, Laura Michalick, Matthew White, Anja Freiwald, Kathrin Textoris-Taube, Spyros I. Vernardis, Anna-Sophia Egger, Marco Kreidl, Daniela Ludwig, Christiane Kilian, Federica Agostini, Aleksej Zelezniak, Charlotte Thibeault, Moritz Pfeiffer, Stefan Hippenstiel, Andreas Hocke, Christof von Kalle, Archie Campbell, Caroline Hayward, David J. Porteous, Riccardo E. Marioni, Claudia Langenberg, Kathryn S. Lilley, Wolfgang M. Kuebler, Michael Mülleder, Christian Drosten, Martin Witzenrath, Florian Kurth, Leif Erik Sander, Markus Ralser
medRxiv 2020.04.27.20081810; doi: https://doi.org/10.1101/2020.04.27.20081810
Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics
Christoph B. Messner, Vadim Demichev, Daniel Wendisch, Laura Michalick, Matthew White, Anja Freiwald, Kathrin Textoris-Taube, Spyros I. Vernardis, Anna-Sophia Egger, Marco Kreidl, Daniela Ludwig, Christiane Kilian, Federica Agostini, Aleksej Zelezniak, Charlotte Thibeault, Moritz Pfeiffer, Stefan Hippenstiel, Andreas Hocke, Christof von Kalle, Archie Campbell, Caroline Hayward, David J. Porteous, Riccardo E. Marioni, Claudia Langenberg, Kathryn S. Lilley, Wolfgang M. Kuebler, Michael Mülleder, Christian Drosten, Martin Witzenrath, Florian Kurth, Leif Erik Sander, Markus Ralser
medRxiv 2020.04.27.20081810; doi: https://doi.org/10.1101/2020.04.27.20081810
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2985)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12840)
- Forensic Medicine (12)
- Gastroenterology (838)
- Genetic and Genomic Medicine (4644)
- Geriatric Medicine (427)
- Health Economics (735)
- Health Informatics (2954)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (937)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4435)
- Nursing (239)
- Nutrition (653)
- Oncology (2308)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1204)
- Primary Care Research (506)
- Public and Global Health (7031)
- Radiology and Imaging (1556)
- Respiratory Medicine (926)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (493)
- Toxicology (60)
- Transplantation (213)
- Urology (185)